|Bid||0.8800 x N/A|
|Ask||0.9100 x N/A|
|Day's Range||0.9100 - 0.9100|
|52 Week Range||0.5200 - 4.4000|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 08, 2022 - Nov 14, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.25|
Nova Cannabis Inc. (the "Company" or "Nova") (TSX: NOVC) today released its unaudited condensed interim consolidated financial statements (the "interim financial statements") and management's discussion and analysis ("MD&A") for the three months ended June 30, 2022. All financial information in this press release is reported in millions of Canadian dollars and represents results from continuing operations, unless otherwise indicated.
Nova Cannabis Inc. (the "Company" or "Nova") (TSX: NOVC) today announced it that plans to release its second quarter 2022 financial results after markets close on August 11, 2022.
Nova Cannabis Inc. ("Nova" or the "Company") (TSX: NOVC) today announced it has established an at-the-market equity offering program (the "ATM Program") that allows the Company to issue up to $20 million of common shares ("Common Shares") from treasury to the public from time to time, at the Company's discretion and subject to regulatory requirements. Any Common Shares sold through the ATM Program will be sold at prevailing market prices when issued in ordinary broker's transactions on the Toron